160 related articles for article (PubMed ID: 33993859)
1. Protein Phosphorylation Signaling Cascades in Autism: The Role of mTOR Pathway.
Boksha IS; Prokhorova TA; Tereshkina EB; Savushkina OK; Burbaeva GS
Biochemistry (Mosc); 2021 May; 86(5):577-596. PubMed ID: 33993859
[TBL] [Abstract][Full Text] [Related]
2. Abnormal mTOR Activation in Autism.
Winden KD; Ebrahimi-Fakhari D; Sahin M
Annu Rev Neurosci; 2018 Jul; 41():1-23. PubMed ID: 29490194
[TBL] [Abstract][Full Text] [Related]
3. mTOR signalling pathway - A root cause for idiopathic autism?
Ganesan H; Balasubramanian V; Iyer M; Venugopal A; Subramaniam MD; Cho SG; Vellingiri B
BMB Rep; 2019 Jul; 52(7):424-433. PubMed ID: 31186084
[TBL] [Abstract][Full Text] [Related]
4. mTOR, a Potential Target to Treat Autism Spectrum Disorder.
Sato A
CNS Neurol Disord Drug Targets; 2016; 15(5):533-43. PubMed ID: 27071790
[TBL] [Abstract][Full Text] [Related]
5. Abnormal mTOR Activity in Pediatric Autoimmune Neuropsychiatric and MIA-Associated Autism Spectrum Disorders.
Trifonova EA; Mustafin ZS; Lashin SA; Kochetov AV
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055151
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial Dysfunction and Its Relationship with mTOR Signaling and Oxidative Damage in Autism Spectrum Disorders.
Yui K; Sato A; Imataka G
Mini Rev Med Chem; 2015; 15(5):373-89. PubMed ID: 25910652
[TBL] [Abstract][Full Text] [Related]
7. [Abnormal mTOR Signaling Pathway Activity in Autism Spectrum Disorders: Prospects of Mechanism-Based Therapy].
Trifonova EA; Kotliarova AA; Kochetov AV
Mol Biol (Mosk); 2023; 57(2):243-253. PubMed ID: 37000653
[TBL] [Abstract][Full Text] [Related]
8. KCNH5 deletion increases autism susceptibility by regulating neuronal growth through Akt/mTOR signaling pathway.
Yu L; Liu Y; Xia J; Feng S; Chen F
Behav Brain Res; 2024 Jul; 470():115069. PubMed ID: 38797494
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of mTOR signaling mediates common neurite and migration defects in both idiopathic and 16p11.2 deletion autism neural precursor cells.
Prem S; Dev B; Peng C; Mehta M; Alibutud R; Connacher RJ; St Thomas M; Zhou X; Matteson P; Xing J; Millonig JH; DiCicco-Bloom E
Elife; 2024 Mar; 13():. PubMed ID: 38525876
[TBL] [Abstract][Full Text] [Related]
10. Restoration of Normal Cerebral Oxygen Consumption with Rapamycin Treatment in a Rat Model of Autism-Tuberous Sclerosis.
Chi OZ; Wu CC; Liu X; Rah KH; Jacinto E; Weiss HR
Neuromolecular Med; 2015 Sep; 17(3):305-13. PubMed ID: 26048361
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of the PI3K catalytic subunit p110δ underlies elevated S6 phosphorylation and protein synthesis in an individual with autism from a multiplex family.
Poopal AC; Schroeder LM; Horn PS; Bassell GJ; Gross C
Mol Autism; 2016; 7():3. PubMed ID: 26770665
[TBL] [Abstract][Full Text] [Related]
12. [Research advances in the role of mTOR signaling pathway in autism spectrum disorder].
Sheng GX; Jiang KW
Zhongguo Dang Dai Er Ke Za Zhi; 2019 Jul; 21(7):718-723. PubMed ID: 31315775
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of the IGF-I/PI3K/AKT/mTOR signaling pathway in autism spectrum disorders.
Chen J; Alberts I; Li X
Int J Dev Neurosci; 2014 Jun; 35():35-41. PubMed ID: 24662006
[TBL] [Abstract][Full Text] [Related]
14. Do Autism Spectrum and Autoimmune Disorders Share Predisposition Gene Signature Due to mTOR Signaling Pathway Controlling Expression?
Trifonova EA; Klimenko AI; Mustafin ZS; Lashin SA; Kochetov AV
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065644
[TBL] [Abstract][Full Text] [Related]
15. Dietary interventions that reduce mTOR activity rescue autistic-like behavioral deficits in mice.
Wu J; de Theije CGM; da Silva SL; Abbring S; van der Horst H; Broersen LM; Willemsen L; Kas M; Garssen J; Kraneveld AD
Brain Behav Immun; 2017 Jan; 59():273-287. PubMed ID: 27640900
[TBL] [Abstract][Full Text] [Related]
16. The mTOR Signaling Pathway Activity and Vitamin D Availability Control the Expression of Most Autism Predisposition Genes.
Trifonova EA; Klimenko AI; Mustafin ZS; Lashin SA; Kochetov AV
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847491
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of Mammalian Target of Rapamycin Signaling in Mouse Models of Autism.
Huber KM; Klann E; Costa-Mattioli M; Zukin RS
J Neurosci; 2015 Oct; 35(41):13836-42. PubMed ID: 26468183
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of translational control signaling in autism spectrum disorders.
Hooshmandi M; Wong C; Khoutorsky A
Cell Signal; 2020 Nov; 75():109746. PubMed ID: 32858122
[TBL] [Abstract][Full Text] [Related]
19. Dysfunctional mTORC1 Signaling: A Convergent Mechanism between Syndromic and Nonsyndromic Forms of Autism Spectrum Disorder?
Magdalon J; Sánchez-Sánchez SM; Griesi-Oliveira K; Sertié AL
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28335463
[TBL] [Abstract][Full Text] [Related]
20. Valproic acid exposure sequentially activates Wnt and mTOR pathways in rats.
Qin L; Dai X; Yin Y
Mol Cell Neurosci; 2016 Sep; 75():27-35. PubMed ID: 27343825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
